Cargando…

Correction: Estrogen receptor beta signaling in CD8+ T cells boosts T cell receptor activation and antitumor immunity through a phosphotyrosine switch

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2021
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8515470/ https://www.ncbi.nlm.nih.gov/pubmed/34645679 http://dx.doi.org/10.1136/jitc-2020-001932corr1

Ejemplares similares

Estrogen receptor beta signaling in CD8(+) T cells boosts T cell receptor activation and antitumor immunity through a phosphotyrosine switch
por: Yuan, Bin, et al.
Publicado: (2021)

A Phosphotyrosine Switch in Estrogen Receptor β Is Required for Mouse Ovarian Function
por: Yuan, Bin, et al.
Publicado: (2021)

Correction: The Tetraspanin-Associated Uroplakins Family (UPK2/3) Is Evolutionarily Related to PTPRQ, a Phosphotyrosine Phosphatase Receptor
por: Chicote, Javier U., et al.
Publicado: (2017)

Correction: Potential Role of Estrogen Receptor Beta as a Tumor Suppressor of Epithelial Ovarian Cancer
por: Bossard, Carine, et al.
Publicado: (2013)

Correction: Adhesion and Degranulation Promoting Adapter Protein (ADAP) Is a Central Hub for Phosphotyrosine-Mediated Interactions in T Cells
por: Sylvester, Marc, et al.
Publicado: (2010)

Correction: Depletion of CD4(+) CD25(+) Regulatory T Cells Promotes CCL21-Mediated Antitumor Immunity
Publicado: (2014)

Correction to: Dynamic switch of immunity and antitumor effects of metformin in rat spontaneous esophageal carcinogenesis
por: Takei, Ryohei, et al.
Publicado: (2021)

Correction: Estrogen Signalling and the Metabolic Syndrome: Targeting the Hepatic Estrogen Receptor Alpha Action
por: Matic, Marko, et al.
Publicado: (2019)

Regions of the T cell receptor alpha and beta chains that are responsible for interactions with CD3
Publicado: (1991)

Phosphotyrosine interactome of the ErbB-receptor kinase family
por: Schulze, Waltraud X, et al.
Publicado: (2005)

A phosphotyrosine switch regulates organic cation transporters
por: Sprowl, Jason A., et al.
Publicado: (2016)

Correction to: TP53 Status as a Determinant of Pro- vs Anti-Tumorigenic Effects of Estrogen Receptor-Beta in Breast Cancer
Publicado: (2023)

Correction: Antineoplastic Effects of α-Santalol on Estrogen Receptor-Positive and Estrogen Receptor-Negative Breast Cancer Cells through Cell Cycle Arrest at G2/M Phase and Induction of Apoptosis
por: Santha, Sreevidya, et al.
Publicado: (2013)

Correction to: MINDY1 promotes breast cancer cell proliferation by stabilizing estrogen receptor α
por: Tang, Jianing, et al.
Publicado: (2022)

Correction: The atypical ubiquitin ligase RNF31 stabilizes estrogen receptor α and modulates estrogen-stimulated breast cancer cell proliferation
por: Zhu, J., et al.
Publicado: (2018)

Correction to: Pharmacokinetic and pharmacodynamic analysis of fulvestrant in preclinical models of breast cancer to assess the importance of its estrogen receptor-α degrader activity in antitumor efficacy
por: Wardell, Suzanne E., et al.
Publicado: (2019)

Correction to: Potentiating CD8(+) T cell antitumor activity by inhibiting PCSK9 to promote LDLR-mediated TCR recycling and signaling
por: Yuan, Juanjuan, et al.
Publicado: (2021)

Correction: Xenoestrogens Alter Estrogen Receptor (ER) α Intracellular Levels
Publicado: (2014)

Correction: Estrogen Mediated-Activation of miR-191/425 Cluster Modulates Tumorigenicity of Breast Cancer Cells Depending on Estrogen Receptor Status
por: Di Leva, Gianpiero, et al.
Publicado: (2013)

Correction: Immunologically programming the tumor microenvironment induces the pattern recognition receptor NLRC4-dependent antitumor immunity
Publicado: (2021)

Probiotics Can Boost the Antitumor Immunity of CD8(+)T Cells in BALB/c Mice and Patients with Colorectal Carcinoma
por: Mao, Jie, et al.
Publicado: (2020)

Publisher Correction: The low affinity neurotrophin receptor CD271 regulates phenotype switching in melanoma
por: Restivo, Gaetana, et al.
Publicado: (2018)

Correction: Toll-like reReceptor 8 agonists improve NK-cell function primarily targeting CD56(bright)CD16(−) subset
Publicado: (2022)

Correction to ‘Control of backbone chemistry and chirality boost oligonucleotide splice switching activity’
Publicado: (2023)

Correction: Dendritic cell therapy augments antitumor immunity triggered by CDK4/6 inhibition and immune checkpoint blockade by unleashing systemic CD4 T-cell responses
Publicado: (2023)

Correction: Estrogenicity of Glabridin in Ishikawa Cells
por: Su Wei Poh, Melissa, et al.
Publicado: (2015)

Correction: CXCR3 chemokine receptor contributes to specific CD8(+) T cell activation by pDC during infection with intracellular pathogens
por: Ferreira, Camila Pontes, et al.
Publicado: (2021)

Phosphotyrosine phosphatase R3 receptors: Origin, evolution and structural diversification
por: Chicote, Javier U., et al.
Publicado: (2017)

Estrogen receptor transcription and transactivation: Estrogen receptor alpha and estrogen receptor beta - regulation by selective estrogen receptor modulators and importance in breast cancer
por: S Katzenellenbogen, Benita, et al.
Publicado: (2000)

Correction: Early Priming Minimizes the Age-Related Immune Compromise of CD8(+) T Cell Diversity and Function
por: Valkenburg, Sophie A., et al.
Publicado: (2012)

Correction: Differential quantities of immune checkpoint-expressing CD8 T cells in soft tissue sarcoma subtypes
Publicado: (2020)

Correction: A Human Trypanosome Suppresses CD8(+) T Cell Priming by Dendritic Cells through the Induction of Immune Regulatory CD4(+) Foxp3(+) T Cells
por: Ersching, Jonatan, et al.
Publicado: (2016)

Inefficient boosting of antitumor CD8(+) T cells by dendritic-cell vaccines is rescued by restricting T-cell cytotoxic functions
por: Zhi-Iong Ma, Joel, et al.
Publicado: (2012)

Estrogen receptor-beta sensitizes breast cancer cells to the anti-estrogenic actions of endoxifen
por: Wu, Xianglin, et al.
Publicado: (2011)

Myc‐dependent endothelial proliferation is controlled by phosphotyrosine 1212 in VEGF receptor‐2
por: Testini, Chiara, et al.
Publicado: (2019)

Correction: CD8(+) T cells provide immune protection against murine disseminated endotheliotropic Orientia tsutsugamushi infection
por: Xu, Guang, et al.
Publicado: (2017)

Recent advances in synthetic and medicinal chemistry of phosphotyrosine and phosphonate-based phosphotyrosine analogues
por: Makukhin, Nikolai, et al.
Publicado: (2020)

Correction: PD-L1 Expression on Retrovirus-Infected Cells Mediates Immune Escape from CD8+ T Cell Killing
por: Akhmetzyanova, Ilseyar, et al.
Publicado: (2015)

Estrogen receptor transcription and transactivation: Antitumor potential of bisphosphonates
por: Green, JR
Publicado: (2001)

Regulation of CD8(+) T Cells and Antitumor Immunity by Notch Signaling
por: Tsukumo, Shin-ichi, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_mmm455cblg1rcd16tgrvlbrdek